ORIGINAL PAPER
Coexistence of frailty syndrome and the level of health behaviors in elderly patients with chronic obstructive pulmonary disease
1
Women’s Internal Medicine Department, Independent Public Healthcare Center, Kępno, Poland Head of the Department: Ewa Łopińska MD
2
Institute of Health Sciences, University of Opole, Opole, Poland Head of the Institute: Prof. Henryk Kozłowski PhD
3
Department of Education and Research in Health Sciences, Faculty of Health Science, Medical University of Warsaw, Warsaw, Poland Head of the Department: Prof. Joanna Gotlib MD, PhD
Submission date: 2022-09-13
Final revision date: 2022-11-24
Acceptance date: 2023-01-26
Publication date: 2023-03-31
Corresponding author
Katarzyna Szwamel
Katarzyna Szwamel PhD Institute of Health Sciences University of Opole 68 Katowicka St 45-060 Opole, Poland
Katarzyna Szwamel PhD Institute of Health Sciences University of Opole 68 Katowicka St 45-060 Opole, Poland
Medical Studies 2023;39(1):32-44
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The acceleration of the aging rate of the population, the associated risk of frailty syndrome and the increase in the number of people living with chronic obstructive pulmonary disease (COPD) mean that future health policy should focus on activities in the field of health promotion, enhancing health behavior, and maintaining or improving the functional fitness of aging people.
Aim of the research:
To analyze the coexistence of frailty syndrome and the severity of health behaviors in elderly patients with COPD as well as established factors determining the severity of health behaviors.
Material and methods:
A hundred COPD patients (mean age: 72.82 ±8.31 years) hospitalized in the Independent Public Healthcare Center in Kępno, Poland were examined. The COPD Assessment Test (CAT), mMRC Dyspnea Severity Scale, Tilburg Frailty Index (TFI), and Health Behavior Inventory were used.
Results:
Ninety-two percent had frailty syndrome. The mean value of the TFI index was 9.31 ±2.97. A group of 53% had high intensity, 35% had average intensity, and 11% had low intensity of health behaviors. The strongest positive predictors of health behaviors were the presence of two or more chronic diseases in addition to COPD itself (ßstd = 0.42; p < 0.001) and higher results obtained on the CAT scale (ßstd = 0.38; p < 0.001). The severity of most health behaviors decreased with the duration of COPD, while the severity of health practices increased with age.
Conclusions:
Health promotion and health education activities should be aimed at those COPD patients who have been ill for a long period of time as well as at younger patients.
The acceleration of the aging rate of the population, the associated risk of frailty syndrome and the increase in the number of people living with chronic obstructive pulmonary disease (COPD) mean that future health policy should focus on activities in the field of health promotion, enhancing health behavior, and maintaining or improving the functional fitness of aging people.
Aim of the research:
To analyze the coexistence of frailty syndrome and the severity of health behaviors in elderly patients with COPD as well as established factors determining the severity of health behaviors.
Material and methods:
A hundred COPD patients (mean age: 72.82 ±8.31 years) hospitalized in the Independent Public Healthcare Center in Kępno, Poland were examined. The COPD Assessment Test (CAT), mMRC Dyspnea Severity Scale, Tilburg Frailty Index (TFI), and Health Behavior Inventory were used.
Results:
Ninety-two percent had frailty syndrome. The mean value of the TFI index was 9.31 ±2.97. A group of 53% had high intensity, 35% had average intensity, and 11% had low intensity of health behaviors. The strongest positive predictors of health behaviors were the presence of two or more chronic diseases in addition to COPD itself (ßstd = 0.42; p < 0.001) and higher results obtained on the CAT scale (ßstd = 0.38; p < 0.001). The severity of most health behaviors decreased with the duration of COPD, while the severity of health practices increased with age.
Conclusions:
Health promotion and health education activities should be aimed at those COPD patients who have been ill for a long period of time as well as at younger patients.
REFERENCES (46)
1.
Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I; NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med 2022; 10: 447-458.
2.
Cortopassi F, Gurung P, Pinto-Plata V. Chronic obstructive pulmonary disease in elderly patients. Clin Geriatr Med 2017; 33: 539-552.
3.
World Health Organization. The top 10 causes of death. https://www.who.int/news-room/... (access: 2022.04.17).
4.
Blanco I, Diego I, Bueno P, Casas-Maldonado F, Miravitlles M. Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps. Eur Respir J 2019; 54: 1900610.
5.
Kałucka S. Najnowsze wytyczne postępowania w przewlekłej obturacyjnej chorobie płuc na rok 2019/2020 – GOLD 2019/2020. Część I. Epidemiologia, etiologia, rozpoznanie. Geriatria 2020; 14: 5-15.
6.
Ministerstwo Zdrowia (2018). Mapa potrzeb zdrowotnych w zakresie chorób układu oddechowego (przewlekłych). http://mpz.mz.gov.pl/wp-conten... (access: 2020. 03.06).
7.
Global Initiative for Chronic Obstructive Lung Disease 2022 Report. https://goldcopd.org/2022-gold...# (access: 2022.04.18).
8.
Brandsma CA, Van den Berge M, Hackett TL, Brusselle G, Timens W. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. J Pathol 2020; 250: 624-635.
9.
Kaluźniak-Szymanowska A, Krzymińska-Siemaszko R, Deskur-Śmielecka E, Lewandowicz M, Kaczmarek B, Wieczorowska-Tobis K. Malnutrition, sarcopenia, and malnutrition-sarcopenia syndrome in older adults with COPD. Nutrients 2021; 14: 44.
10.
Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L, van Boven JFM, Brusselle G, Costello RW, Dandurand RJ, Diamant Z, Van Ganse E, Gouder C, van Kampen SC, Kaplan A, Kocks J, Miravitlles M, Niimi A, Pizzichini E, Rhee CK, Soriano JB, Vogelmeier C, Román-Rodriguez M, Carter V, D’Urzo AD, Roche N. Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices. Ann Am Thorac Soc 2019; 16: 1143-1150.
11.
Yee N, Locke ER, Pike KC, Chen Z, Lee J, Huang JC, Nguyen HQ, Fan VS. Frailty in chronic obstructive pulmonary disease and risk of exacerbations and hospitalizations. Int J Chron Obstruct Pulmon Dis 2020; 15: 1967-1976.
12.
van Assen MA, Pallast E, Fakiri FE, Gobbens RJ. Measuring frailty in Dutch community-dwelling older people: reference values of the Tilburg Frailty Indicator (TFI). Arch Gerontol Geriatr 2016; 67: 120-129.
13.
Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 2012; 60: 1487-1492.
14.
WHO clinical consortium on healthy ageing: topic focus: frailty and intrinsic capacity: report of consortium meeting, 1–2 December 2016 in Geneva, Switzerland. https://apps.who.int/iris/hand... (accessed: 2022.07.30).
15.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: 146-156.
16.
Ijaz N, Buta B, Xue QL, Mohess DT, Bushan A, Tran H, Batchelor W, deFilippi CR, Walston JD, Bandeen-Roche K, Forman DE, Resar JR, O’Connor CM, Gerstenblith G, Damluji AA. Interventions for frailty among older adults with cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol 2022; 79: 482-503.
17.
Kojima G, Liljas AEM, Iliffe S. Frailty syndrome: implications and challenges for health care policy. Risk Manag Healthc Policy 2019; 12: 23-30.
18.
McKenzie K, Martin L, Ouellette-Kuntz H. Frailty and intellectual and developmental disabilities: a scoping review. Can Geriatr J 2016; 19: 103-112.
19.
Uchmanowicz I, Wleklik M, Gobbens RJ. Frailty syndrome and self-care ability in elderly patients with heart failure. Clin Interv Aging 2015; 10: 871-877.
20.
Uchmanowicz I, Młynarska A, Lisiak M, Kałużna-Olek- sy M, Wleklik M, Chudiak A, Dudek M, Migaj J, Hinterbuchner L, Gobbens R. Heart failure and problems with frailty syndrome: why it is time to care about frailty syndrome in heart failure. Card Fail Rev 2019; 5: 37-43.
21.
Lahousse L, Ziere G, Verlinden VJ, Zillikens MC, Uitterlinden AG, Rivadeneira F, Tiemeier H, Joos GF, Hofman A, Ikram MA, Franco OH, Brusselle GG, Stricker BH. Risk of frailty in elderly with COPD: a population-based study. J Gerontol A Biol Sci Med Sci 2016; 71: 689-695.
22.
Freiberger E, Kemmler W, Siegrist M, Sieber C. Frailty and exercise interventions: evidence and barriers for exercise programs. Z Gerontol Geriatr 2016; 49: 606-611.
23.
Wleklik M, Uchmanowicz I, Jankowska EA, Vitale C, Li- siak M, Drozd M, Pobrotyn P, Tkaczyszyn M, Lee C. Multidimensional approach to frailty. Front Psychol 2020; 11: 564.
24.
Jaroch A. Zalecenia dotyczące spożycia białka dla pacjentów geriatrycznych z zespołem słabości. Gerontol Pol 2015; 3: 47-51.
25.
Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy- Westphal A, Cederholm T, Cruz-Jentoft A, Krznariç Z, Nair KS, Singer P, Teta D, Tipton K, Calder PC. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr 2014; 33: 929-936.
26.
Soll A, Szwamel K, Bujnowska-Fedak MM, Kurpas D. Zespół słabości w opiece środowiskowej: wskazówki dla pacjentów i ich opiekunów. Med Sci Pulse 2017; 11: 31-36.
27.
Jahnz-Różyk K, Czajkowska-Malinowska M, Krenke K, Sands D, Batura Gabryel H, Kabicz P, Diaków E, Więckowska B. Analysis of hospital management of chronic respiratory diseases in light of the Maps of Health Needs project in Poland. Adv Respir Med 2020; 88: 297-304.
28.
Śliwiński P, Górecka D, Jassem E, Pierzchała W. Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczące rozpoznawania i leczenia przewlekłej obturacyjnej choroby płuc. Pneumonol Alergol Pol 2014; 82: 227-263.
29.
Chazan R. Nowe możliwości terapeutyczne w POChP. Pneumonol Alergol Pol 2013; 81: 154-161.
30.
Brożek B, Damps-Konstańska I, Schiller M, Krajnik M. Czynniki wpływające na prognozowanie w przewlekłej obturacyjnej chorobie płuc (POChP). Palliat Med Pract 2015; 9: 39-45.
31.
Kupryś-Lipińska I. Wytyczne GOLD – aktualizacja 2011. Med Dypl 2012. https://podyplomie.pl/medycyna..., nowosci-w-praktyce?page=7 (accessed: 2020.04.30).
32.
Gobbens RJ, van Assen MA, Luijkx KG, Wijnen-Spon- selee MT, Schols JM. The Tilburg frailty indicator: psychometric properties. J Am Med Dir Assoc 2010; 11: 344-355.
33.
Uchmanowicz I, Jankowska-Polańska B, Łoboz-Rudnic- ka M, Manulik S, Łoboz-Grudzień K, Gobbens RJ. Cross- cultural adaptation and reliability testing of the Tilburg Frailty Indicator for optimizing care of Polish patients with frailty syndrome. Clin Interv Aging 2014; 9: 997-1001.
34.
Juczyński Z. Narzędzia pomiaru w promocji i psychologii zdrowia. Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego, Warszawa 2012.
35.
Cichońska M, Maciąg D, Pypeć U, Wasilewska J. Postawy zdrowotne i zachowania chorych na przewlekłą obturacyjną chorobę płuc, a ich wiek. Polish J Health and Fitness 2015; 1: 13-32.
36.
Kennedy CC, Novotny PJ, LeBrasseur NK, Wise RA, Sciurba FC, Benzo RP. Frailty and clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc 2019; 16: 217-224.
37.
Park SK. Frailty in Korean patients with chronic obstructive pulmonary disease, using data from the Korea National Health and Nutrition Examination Survey, 2015 and 2016. Appl Nurs Res 2021; 59: 151417.
38.
Zhang H, Wu F, Yi H, Xu D, Jiang N, Li Y, Li M, Wang K. Gender differences in chronic obstructive pulmonary disease symptom clusters. Int J Chron Obstruct Pulmon Dis 2021; 16: 1101-1107.
39.
Luo J, Zhang D, Tang W, Dou LY, Sun Y. Impact of frailty on the risk of exacerbations and all-cause mortality in elderly patients with stable chronic obstructive pulmonary disease. Clin Interv Aging 2021; 16: 593-601.
40.
Kusunose M, Oga T, Nakamura S, Hasegawa Y, Nishimu- ra K. Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities? BMJ Open Respir Res 2017; 4: e000196.
41.
Uchmanowicz I, Jankowska-Polanska B, Chabowski M, Uchmanowicz B, Fal AM. The influence of frailty syndrome on acceptance of illness in elderly patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2016; 11: 2401-2407.
42.
Bernabeu-Mora R, Garcia-Guillamón G, Valera-Novella E, Giménez-Giménez LM, Escolar-Reina P, Medina-Mira- peix F. Frailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: a longitudinal study. Ther Adv Respir Dis 2017; 11: 383-392.
43.
de Souza Dias L, Galvão Ferreira AC, da Silva JLR, Con- te MB, Rabahi MF. Prevalence of frailty and evaluation of associated variables among COPD patients. Int J Chron Obstruct Pulmon Dis 2020; 15: 1349-1356.
44.
Gobbens RJ, Uchmanowicz I. Assessing frailty with the Tilburg Frailty Indicator (TFI): a review of reliability and validity. Clin Interv Aging 2021; 16: 863-875.
45.
Kropornicka B, Baczewska B, Czerwonka E, Nowicka E, Daniluk J. Health behaviors in patients suffering from chronic obstructive pulmonary disease. Przedsiębiorczość i Zarządzanie 2014; 15: 99-112.
46.
Grochowska A, Zając P, Bodys-Cupak I, Łabuzek M, Maciejewska J. Health behaviors of patiens with COPD. Pol Prz Nauk Zdr 2019; 58: 44-50.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
